Long-term sotatercept treatment of pulmonary arterial hypertension: pooled analysis of efficacy and safety
Extract Sotatercept is a first-in-class activin-signalling inhibitor approved for treatment of pulmonary arterial hypertension (PAH) [1–3]. SOTERIA ( NCT07218029 ) is a phase III, single-arm, open-label, follow-up study assessing long-term safety, tolerability and efficacy of sotatercept in adults with PAH who participated in a parent sotatercept study [4]. Analysis of pooled data from time of SOTERIA entry through 1 year (mean 15 months) of treatment with sotatercept was previously reported [4]. Here, we provide a novel, more comprehensive and updated analysis of SOTERIA participants from the time of sotatercept initiation (during the parent study or, for those receiving placebo throughout the parent study, at rollover into SOTERIA) up to a median of 2.5 years.
Authors
- Ioana R. Preston (ORCID: https://orcid.org/0000-0002-1378-7362)
- Marius M. Hoeper (ORCID: https://orcid.org/0000-0001-9086-2293)
- Howard Martin Julien (ORCID: https://orcid.org/0000-0002-4130-097X)
- Harald S. Mackenzie
- Aaron B. Waxman (ORCID: https://orcid.org/0000-0001-7797-0361)
- Loı̈c Perchenet
- J. Simon R. Gibbs (ORCID: https://orcid.org/0000-0001-6147-9252)
- Mardi Gomberg‐Maitland (ORCID: https://orcid.org/0000-0003-0482-4560)
- David B. Badesch
- Vallerie V. McLaughlin (ORCID: https://orcid.org/0000-0002-8907-1651)
- Marc J.C. Humbert (ORCID: https://orcid.org/0000-0003-0703-2892)
- Hossein Ardeschir Ghofrani (ORCID: https://orcid.org/0000-0002-2029-4419)
- James Strait (ORCID: https://orcid.org/0009-0004-5465-439X)
- Alexandra G. Cornell
- Barry Miller
- Jianxin Lin
- Yaru Shi
- Rogerio Souza
Institutions
- Brigham and Women's Hospital (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Lahey Hospital and Medical Center (US)
- Harvard University (US)
- Inserm (FR)
- George Washington University (US)
- Justus-Liebig-Universität Gießen (DE)
- Université Paris-Saclay (FR)
- University of Michigan (US)
- University of Colorado System (US)
- Medizinische Hochschule Hannover (DE)
- Assistance Publique – Hôpitaux de Paris (FR)
- Lahey Medical Center (US)
- German Center for Lung Research (DE)
- Universities of Giessen and Marburg Lung Center (DE)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Bicêtre Hospital (FR)
- Instituto do Coração - HCFMUSP (BR)
- Imperial College London (GB)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1183/23120541.01546-2026
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00